Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 

1. STOCK NEWS: 

• Netflix (NFLX) shares have lost over a third of their value after the company unexpectedly lost 200,000 subscribers in the first quarter [more]
• Procter & Gamble (PG) reported better-than-expected Q3 earnings and revenue [more]
  
• Abbott (ABT) reported upbeat Q1 results and reiterated its FY22 earnings guidance [more]
  
• IBM (IBM) also reported upbeat Q1 results [more]
  
• Lululemon (LULU) announced a five year growth plan to double revenue to $12.5B by 2026 [more]
  

2. WALL STREET CALLS: 

• Pivotal Research and BofA double-downgraded Netflix (NFLX) to Sell-equivalent ratings after the company's "shocking" subscriber decline while a slew of others on Wall Street went to Hold ratings on the streaming giant after last night's earnings report [more]
• Citi analyst Ronald Josey upgraded Alphabet (GOOGL) to Buy from Neutral after assuming coverage of the internet sector [more]
  
• Halliburton (HAL) downgraded to Equal Weight at Stephens following outperformance [more]
  
• Barclays upgrades Avis (CAR) to neutral on "constructive" rental stance [more]
  
• Alkermes (ALKS) initiated with a Buy at Goldman Sachs [more]
  

3. AROUND THE WEB: 

• I-Mab (IMAB) is exploring a possible sale amid takeover interest, Bloomberg reports [more]
• Trump-linked Digital World Acquisition (DWAC) was named as a short idea by Kerrisdale Capital [more]
  
• Shopify (SHOP) and Facebook (FB) are at adds over data, The Information reports [more]
  
• Tweet from Tesla's (TSLA) Elon Musk hints at tender offer for Twitter, WSJ says [more]
  
• Warner Bros. Discovery (WBD) is reviewing CNN+ and plans to cut costs, NY Post says [more]
  

4. MOVERS: 

• AlloVir (ALVR) soars after announcing the FDA granted Regenerative Medicine Advanced Therapy designation for posoleucel [more]
• Cano Health (CANO) rises after UBS analyst Andrew Monk initiated coverage of the stock with a Buy rating and $15 price target [more]
  
• Healthcare Services (HCSG) advances after reporting quarterly results [more]
  
• Arcturus Therapeutics (ARCT) declines after reporting data from its ongoing Phase 1/2/3 trial evaluating its mRNA vaccine candidate against COVID-19 disease [more]
  
• Volta (VLTA) falls after Goldman Sachs analyst Mark Delaney downgraded the stock to Sell [more]
  

5. EARNINGS/GUIDANCE: 

• Baker Hughes (BKR) reported downbeat Q1 results [more]
• Anthem (ANTM) reported better-than-expected Q1 earnings and revenue [more]
  
• Farmers & Merchants (FMAO) reported upbeat Q1 earnings [more]
  
• Berkshire Hills Bancorp (BHLB) also reported upbeat Q1 earnings [more]
  
• Rogers Communications (RCI) raised its FY22 revenue guidance [more]
  

INDEXES: 

Near midday, the Dow was up 325.29, or 0.93%, to 35,236.49, the Nasdaq was down 120.76, or 0.89%, to 13,498.90, and the S&P 500 was up 12.23, or 0.27%, to 4,474.44.